← Back to guidelines
Dermatology2 papers

Malignant melanoma of skin of umbilicus

Last edited: 4/10/2026

Overview

Malignant melanoma is a potentially dangerous skin tumor responsible for the majority of skin cancer mortality 1. Cutaneous melanoma can occur in various locations, including the umbilicus.

Diagnosis

  • Clinical diagnosis should always be confirmed with dermatoscopy 1.
  • Histopathological examination is required for suspected melanoma 1.
  • Sequential digital dermatoscopy and full body photography may aid in early detection in high-risk patients 1.
  • Confocal reflectance microscopy can improve clinical diagnosis in specific cases 1.
  • Melanoma classification follows the 8th edition of the American Joint Committee on Cancer staging 1.
  • Management

  • Thin melanomas (up to 0.8 mm thickness) do not require further imaging diagnostics 1.
  • From stage IB onwards, lymph node sonography is recommended 1.
  • From stage IIC onwards, whole-body examinations with CT or PET-CT combined with brain MRI are recommended 1.
  • From stage III and higher, mutation testing, particularly for BRAF V600 mutation, is recommended 1.
  • Key Recommendations

  • Melanoma diagnosis should be made clinically and confirmed with dermatoscopy, followed by histopathological examination 1. (Evidence: Expert opinion)
  • From stage IB, lymph node sonography is recommended for melanoma staging 1. (Evidence: Expert opinion)
  • From stage IIC, whole-body imaging (CT or PET-CT) and brain MRI are recommended for staging 1. (Evidence: Expert opinion)
  • References

    1 Garbe C, Amaral T, Peris K, Hauschild A, Arenberger P, Basset-Seguin N et al.. European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics: Update 2022. European journal of cancer (Oxford, England : 1990) 2022. link

    Original source

    1. [1]
      European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics: Update 2022.Garbe C, Amaral T, Peris K, Hauschild A, Arenberger P, Basset-Seguin N et al. European journal of cancer (Oxford, England : 1990) (2022)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG